SCHEMBL295709

SCHEMBL295709

CC1=CCC(CCC(C)CO)C1(C)C

nearest known ligand 0.35

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TSHR P16473 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19631244 1.00 USP2 (0.35) USP2NPSR1TSHRTDP1
SCHEMBL14843824 1.00 USP2 (0.35) USP2NPSR1TSHRTDP1
SCHEMBL29375015 1.00 USP2 (0.35) USP2NPSR1TSHRTDP1
SCHEMBL19631246 1.00 USP2 (0.35) USP2NPSR1TSHRTDP1
SCHEMBL9051230 1.00 USP2 (0.35) USP2NPSR1TSHRTDP1
SCHEMBL17907440 0.89 USP2 (0.35) USP2NPSR1TDP1
SCHEMBL22715822 0.85 USP2 (0.36) USP2NPSR1TDP1
SCHEMBL21924630 0.84
SCHEMBL17631919 0.83 USP2 (0.38) USP2NPSR1TDP1
SCHEMBL10709913 0.81 ALDH1A1 (0.34) USP2NPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 540 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4302747-B1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT OREAL (FR) 2026-01-14 EP claimed
EP-4545063-A1 COSMETICAL USE OF A TOPICALLY APPLICABLE RINSE-OF COMPOSITION (RC) Wella Germany GmbH (DE) 2025-04-30 EP claimed
US-20250127701-A1 Cosmetical use of a topically applicable rinse-of composition (RC) WELLA GERMANY GMBH (DE) 2025-04-24 US claimed
US-12239209-B2 System for dispensing a cosmetic product L'OREAL (FR) 2025-03-04 US claimed
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety THE PROCTER & GAMBLE COMPANY (US) 2025-02-25 US claimed
US-20250051370-A1 SILICONE COMPOUNDS PROCTER & GAMBLE (US) 2025-02-13 US claimed
EP-4302747-A1 SYSTEM FOR DISPENSING A COSMETIC PRODUCT L'OREAL (FR) 2024-01-10 EP claimed
US-11603506-B2 Product comprising a plastic container and a substance composition SYMRISE AG (DE) 2023-03-14 US claimed
US-11447724-B2 Compositions that include siloxane compounds having pendant silyl ether moieties THE PROCTER & GAMBLE COMPANY (US) 2022-09-20 US claimed
CN-114847617-A System for dispensing a cosmetic product 欧莱雅 2022-08-05 CN claimed
EP-2099421-B1 ANTIMICROBIAL FLAVOURING COMPOSITION FIRMENICH & CIE (CH) 2010-06-30 EP claimed
EP-2174645-A2 Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate Symrise GmbH & Co. KG (DE) 2010-04-14 EP claimed
EP-2158896-A2 Materials containing aromas incorporating neopentyl glycol isononanoate Symrise GmbH & Co. KG (DE) 2010-03-03 EP claimed
EP-2142631-A1 METHODS FOR TREATING FABRIC IN A DRYER The Dial Company (US) 2010-01-13 EP claimed
US-7491833-B2 Valerolactone compounds and perfume composition KAO CORPORATION (JP) 2009-02-17 US claimed
WO-2008134212-A1 METHODS FOR TREATING FABRIC IN A DRYER THE DIAL COMPANY (US) 2008-11-06 WO claimed
US-20060258559-A1 Valerolactone compounds and perfume composition KAO CORPORATION (JP) 2006-11-16 US claimed
EP-1555261-A1 VALEROLACTONE COMPOUNDS AND PERFUME COMPOSITION Kao Corporation (JP) 2005-07-20 EP claimed
EP-1056739-B1 NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE PROCTER & GAMBLE (US) 2003-05-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250051370-A1 SILICONE COMPOUNDS SMCHD1, SRI, SMS USP2 2636/4885NPSR1 2458/4885TSHR 3842/4885
US-12239209-B2 System for dispensing a cosmetic product PDE12, SAMM50, POLR1C USP2 3135/4885NPSR1 2713/4885TSHR 1719/4885
US-12234253-B2 Silicone compounds with a substituted amine group and a benefit agent moiety SMS, SRM, AAAS USP2 2777/4885NPSR1 611/4885TSHR 3016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.